Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
POLICY PAPERS
January 31, 2024
Despite the increasing imperative for cross-provider collaboration, the quest for a truly “global” development paradigm remains elusive, marked by persistent divides between different types of development providers’ normative frameworks, models, experiences, capacities, and institutional allegiances...
POLICY PAPERS
November 08, 2023
Haiti is once more experiencing a crisis of instability and political unrest. The devastating 2010 earthquake was seen as a chance to break with the past and steer the nation in a new direction, but although some progress was made, it was short-lived, insufficient to establish a path for growth, une...
POLICY PAPERS
October 02, 2023
Development economics is turning a full circle with a difference. This paper addresses the circling back to the policies in vogue during the 1980s and earlier, including industrial policies, coupled with protectionism; accounts for the regression to earlier certitudes after an extended spell of glob...
POLICY PAPERS
August 07, 2023
CGD conducted a landscaping exercise to better understand the current landscape of organizations headquartered in sub-Saharan Africa that boast impact evaluation capacity. The resulting database is intended as a resource for funders looking to advance locally led development; to help facilitate coor...
POLICY PAPERS
May 19, 2023
Most non-DAC cooperation providers show openness to multi-partner engagement for development, but whether and how such openness can be transformed into more active cooperation—if not deeper collaboration—for development, including between DAC and non-DAC actors, remains to be seen.
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
POLICY PAPERS
November 15, 2022
Antimicrobial drugs form the backbone of modern medicine. Yet over time, use of these drugs selects for mutations that survive exposure to those same drugs, driving “antimicrobial resistance,” or AMR. In the absence of sufficient R&D investment for new antimicrobials, deaths from drug-resistant infe...
POLICY PAPERS
October 04, 2022
In this paper, we report the results of a horizon-scanning exercise to source opportunities for global health R&D investment—that is, high-value potential biomedical innovations which are currently underfunded but which could be transformative for health, quality of life, and health security in LMIC...